The stock of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) is a huge mover today! About 358,223 shares traded hands or 12.83% up from the average. Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) has declined 28.57% since February 29, 2016 and is downtrending. It has underperformed by 40.79% the S&P500.
The move comes after 8 months positive chart setup for the $94.62M company. It was reported on Oct, 3 by Barchart.com. We have $9.53 PT which if reached, will make NASDAQ:EKSO worth $88.94M more.
Analysts await Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) to report earnings on November, 3. They expect $-0.44 earnings per share, down 25.71% or $0.09 from last year’s $-0.35 per share. After $-0.71 actual earnings per share reported by Ekso Bionics Holdings, Inc. for the previous quarter, Wall Street now forecasts -38.03% EPS growth.
According to Zacks Investment Research, “Ekso Bionics Holdings, Inc. is engaged in designing, developing and selling wearable robots or exoskeletons for the medical, military, industrial and consumer markets. The company’s operating segment consists of Engineering Services and Medical segments. It operates primarily in North America, Western Europe, the Middle East and South Africa. Ekso Bionics Holdings, Inc. is headquartered in Richmond, California.”
More important recent Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) news were published by: Marketwatch.com which released: “Ekso Bionics Holdings Inc.” on January 19, 2014, also Globenewswire.com published article titled: “Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) to Ring The Nasdaq Stock Market …”, Quotes.Wsj.com published: “News Ekso Bionics Holdings Inc.EKSO” on March 05, 2014. More interesting news about Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) was released by: Seekingalpha.com and their article: “Ekso Bionics Is Fulfilling Its Commercial Ambitions” with publication date: June 16, 2016.
EKSO Company Profile
Ekso Bionics Holdings, Inc., formerly PN Med Group, Inc., incorporated on January 30, 2012, designs, develops and sells wearable bionic human exoskeletons that have applications in healthcare, industrial, military and consumer markets. The Firm operates through two divisions: Engineering Services and Medical. The Engineering Services segment is engaged in collaborative research and development service arrangements, technology license agreements and government grants where it uses its robotics domain knowledge in bionic exoskeletons to bid on and procure contracts and grants from entities, such as the National Science Foundation and the Defense Advanced Research Projects Agency. The Medical segment designs, engineers and makes exoskeletons for applications in the medical and military markets. The Company’s exoskeleton systems are worn over the user’s clothing. These systems serve various markets, which can be used both by able-bodied users, as well as by persons with physical disabilities.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.